Clover Health Investments Corp (NASDAQ:CLOV) reported Q3 revenue of $482.07 million, missing the consensus estimate of $494.6 million. Insurance revenues were up 12% YoY to $301.2 million. The company reported an adjusted EBITDA loss of $5.1 million, improved from a loss of $55.5 million YoY. Clover Health revised its 2023 adjusted EBITDA outlook from a loss of $70 million to $120 million to a loss of $55 million to $80 million. The company updated its full-year 2023 insurance revenue outlook from a range of $1.2 to $1.23 billion to a new range of $1.21 to $1.23 billion.